Process-Specific Mixing Tank Solution for mRNA-LNP Sterile Formulation
We deliver fully customized cGMP-grade mixing tanks exclusively engineered for sensitive mRNA-LNP formulation and preparation processes in vaccine manufacturing. Unlike conventional biopharmaceutical mixing equipment, mRNA-LNP production demands ultra-low-shear blending, strict temperature locking, absolute aseptic isolation, and precise proportional mixing to preserve mRNA integrity and ensure uniform lipid nanoparticle encapsulation. Our tailor-made mixing tank system is precisely optimized for core LNP formulation workflows, including lipid phase dissolution, aqueous mRNA buffer preparation, microfluidic mixing post-processing, and final sterile homogenization, providing a dedicated, stable core device for high-quality mRNA vaccine formulation.
Low-Shear & Precision-Controlled Structural Optimization for LNP Stability
Our customized mixing tank adopts specialized low-shear stirring structure and optimized fluid flow design to avoid mechanical damage to fragile mRNA strands and prevent LNP particle agglomeration or structural rupture. Featuring full 316L sanitary stainless steel construction, dead-leg-free pipeline design and fully sealed aseptic cavity, the tank eliminates residual contamination and external microbial intrusion. Integrated ultra-precise constant-temperature control systems, real-time viscosity monitoring and uniform mixing calibration ensure consistent particle size distribution, high encapsulation efficiency and excellent batch-to-batch homogeneity for mRNA-LNP complexes, meeting the rigorous physical and biochemical quality requirements of nucleic acid vaccine formulations.
Full cGMP Compliance & Complete Validation Traceability
All structural design, component selection, mechanical processing and functional testing of the mRNA-LNP dedicated mixing tank strictly comply with FDA, EMA and global cGMP regulatory standards for novel nucleic acid drugs. The system supports automated CIP/SIP circulation cleaning and sterilization, achieving repeatable and verifiable aseptic operation status. We provide complete equipment qualification documents including DQ, IQ, OQ and PQ, full material certification and standardized batch operation traceability data. Every functional module and operational parameter is validated to eliminate formulation deviation and compliance risks, fully adapting to regulatory audit and formal commercial production requirements.
Flexible Customization & Scalable Layout for mRNA Industrialization
Tailored for diversified mRNA vaccine development and scale-up production, our customized LNP mixing tank supports flexible customization of tank volume, stirring parameters, temperature control range, sensor configuration and automated linkage functions. The modular design seamlessly adapts from laboratory process exploration and clinical trial batch preparation to large-scale commercial mass production, reserving sufficient expansion space for multi-strain vaccine iteration and capacity upgrading. With ultra-high formulation stability, low operational loss and long-term reliable performance, the specialized mixing tank builds a solid compliant foundation for efficient, standardized and large-scale industrial manufacturing of mRNA-LNP vaccines.
